Delivery Order SPE2DB20D3505-SPE2DB25FV0V9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $7,389.26. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a $15,063.99 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This competitively awarded, firm fixed-price contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside transaction, indicating the contract was open to all qualified...
- The Defense Logistics Agency awarded a delivery order valued at $4,958.04 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a $5,629.86 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters location of the prime contractor. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $25,721.23 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, and performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a $16,835.46 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ondansetron ODT 4 MG tablets in quantities of 30 units. This firm fixed-price delivery order, set to complete by July 22, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $10,347.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside competitive award for pharmaceutical products supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $8,001.71. This is a firm fixed price, non-competitive delivery order executed under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive award, with a ceiling value of $1,781.89, utilizes firm fixed-price delivery order terms and is scheduled for completion by July 23, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count quantity, with a ceiling value of $4,245.12. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation and is scheduled for ultimate completion by July 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV0V9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $6,727.11. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location, supplying this pharmaceutical product to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. This prime IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its significant role as a critical vendor in the Defense Logistics Agency's medical supply chain, fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 7/30/25 |